相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical trials of dual-target CAR T cells, donor-derived CAR T cells, and universal CAR T cells for acute lymphoid leukemia
Juanjuan Zhao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
Terry J. Fry et al.
NATURE MEDICINE (2018)
Chimeric antigen receptor T-cell therapies for lymphoma
Jennifer N. Brudno et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities
Sattva S. Neelapu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
Kevin Bielamowicz et al.
NEURO-ONCOLOGY (2018)
mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targeting
Jason J. Lohmueller et al.
ONCOIMMUNOLOGY (2018)
Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses
Jang Hwan Cho et al.
CELL (2018)
Increasing T Cell Versatility with SUPRA CARs
Yvonne Y. Chen
CELL (2018)
Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
David Porter et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Gcn4 Binding in Coding Regions Can Activate Internal and Canonical 50 Promoters in Yeast
Yashpal Rawal et al.
MOLECULAR CELL (2018)
Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'
Sattva S. Neelapu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Chimeric Antigen Receptor Therapy
Carl H. June et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
Cytokine release syndrome: grading, modeling, and new therapy
Delong Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Universal CARs, universal T cells, and universal CAR T cells
Juanjuan Zhao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing
Zihai Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Zhenguang Wang et al.
BIOMARKER RESEARCH (2018)
New development in CAR-T cell therapy
Zhenguang Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Chimeric antigen receptor T cells: a novel therapy for solid tumors
Shengnan Yu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Inducible Caspase-9 Selectively Modulates the Toxicities of CD19-Specific Chimeric Antigen Receptor-Modified T Cells
Iulia Diaconu et al.
MOLECULAR THERAPY (2017)
Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma
Frederick L. Locke et al.
MOLECULAR THERAPY (2017)
Therapeutic T cell engineering
Michel Sadelain et al.
NATURE (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
Waseem Qasim et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Retargeting of T lymphocytes to PSCA-or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology UniCAR
Anja Feldmann et al.
ONCOTARGET (2017)
Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor model
Elham Pishali Bejestani et al.
ONCOIMMUNOLOGY (2017)
Chimeric antigen receptor T-cell therapies for multiple myeloma
Lekha Mikkilineni et al.
BLOOD (2017)
Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
Guoqing Wei et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2017)
Toxicities of chimeric antigen receptor T cells: recognition and management
Jennifer N. Brudno et al.
BLOOD (2016)
Improving the safety of T-Cell therapies using an inducible caspase-9 gene
Xiaoou Zhou et al.
EXPERIMENTAL HEMATOLOGY (2016)
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
Marco Ruella et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Versatile strategy for controlling the specificity and activity of engineered T cells
Jennifer S. Y. Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies
David T. Rodgers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Adoptive transfer of T cells transduced with a chimeric antigen receptor to treat relapsed or refractory acute leukemia: efficacy and feasibility of immunotherapy approaches
Guoliang Ding et al.
SCIENCE CHINA-LIFE SCIENCES (2016)
Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts
M. Cartellieri et al.
BLOOD CANCER JOURNAL (2016)
T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells
Eugenia Zah et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Redirection of Genetically Engineered CAR-T Cells Using Bifunctional Small Molecules
Min Soo Kim et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia
S. S. Kenderian et al.
LEUKEMIA (2015)
A Novel Ex Vivo Isolation and Expansion Procedure for Chimeric Antigen Receptor Engrafted Human T Cells
Marc Cartellieri et al.
PLOS ONE (2014)
Simultaneous Targeting of Prostate Stem Cell Antigen and Prostate-Specific Membrane Antigen Improves the Killing of Prostate Cancer Cells Using a Novel Modular T Cell-Retargeting System
Claudia Arndt et al.
PROSTATE (2014)
Protein conjugation with genetically encoded unnatural amino acids
Chan Hyuk Kim et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2013)
Retargeting of regulatory T cells to surface-inducible autoantigen La/SS-B
Stefanie Koristka et al.
JOURNAL OF AUTOIMMUNITY (2013)
Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The Basic Principles of Chimeric Antigen Receptor Design
Michel Sadelain et al.
CANCER DISCOVERY (2013)
TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
Zakaria Grada et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
A Universal Strategy for Adoptive Immunotherapy of Cancer through Use of a Novel T-cell Antigen Receptor
Katarzyna Urbanska et al.
CANCER RESEARCH (2012)
Redirecting Gene-Modified T Cells toward Various Cancer Types Using Tagged Antibodies
Koji Tamada et al.
CLINICAL CANCER RESEARCH (2012)
Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling
Scott Wilkie et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Structural basis of RNA binding by leucine zipper GCN4
Yaroslav Nikolaev et al.
PROTEIN SCIENCE (2012)
Development of a novel universal immune receptor for antigen targeting To Infinity and beyond
Katarzyna Urbanska et al.
ONCOIMMUNOLOGY (2012)
Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease
Daniel J. O'Shannessy et al.
SPRINGERPLUS (2012)
Folate receptor α A storied past and promising future in immunotherapy
Guy T. Clifton et al.
HUMAN VACCINES (2011)
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Antonio Di Stasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Folate-Targeted Therapies for Cancer
Wei Xia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Affinity-matured recombinant antibody fragments analyzed by single-molecule force Spectroscopy
Julia Morfill et al.
BIOPHYSICAL JOURNAL (2007)
Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjogren's syndrome -: Prevalence and clinical significance in 335 patients
N Nardi et al.
CLINICAL RHEUMATOLOGY (2006)
Neo-epitopes are required for immunogenicity of the La/SS-B nuclear antigen in the context of late apoptotic cells
ZJ Pan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
An inducible caspase 9 safety switch for T-cell therapy
KC Straathof et al.
BLOOD (2005)
分享论文
